detinfДЕТСКИЕ ИНФЕКЦИИCHILDREN INFECTIONS2072-81072618-8139Association of Pediatricians and Infection Disease doctors10.22627/2072-8107-2023-22-2-43-48detinf-842Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEW OF THE LITERATUREСочетанная инфекция COVID-19 с ОРИ различной этиологии у детей: распространенность и особенности теченияСombined infection of COVID-19 with ARI of various etiologies in children: prevalence and features of the coursehttps://orcid.org/0000-0002-7557-2236ДрачеваН. А.DrachevaN. A.

Драчева Наталья Алексеевна, врач-педиатр, аспирант кафедры детских инфекционных болезней

Москва

Moscow

tan1809@mail.ruhttps://orcid.org/0000-0002-0895-6707МазанковаЛ. Н.MazankovaL. N.

Мазанкова Людмила Николаевна, д.м.н., профессор, зав. кафедрой детских инфекционных болезней педиатрического факультета, гл. внештатный специалист по инфекционным болезням у детей

Москва

Moscow

ФГБОУ ДПО Российская медицинская академия непрерывного профессионального образования (РМАНПО) Минздрава РоссииРоссияRussian Medical Academy of Continuous Professional Education of the Ministry of Health of RussiaRussian Federation2023270620232224348Copyright © Драчева Н.А., Мазанкова Л.Н., 20232023Драчева Н.А., Мазанкова Л.Н.Dracheva N.A., Mazankova L.N.This work is licensed under a Creative Commons Attribution 4.0 License.https://detinf.elpub.ru/jour/article/view/842

Актуальность проблемы сочетанной инфекции COVID-19 с ОРИ различной этиологии обусловлена высокой распространенностью респираторных инфекций в период эпидемии коронавирусной инфекции. Распространенность сочетанных инфекций COVID-19 с ОРИ по данным литературы варьирует от 0,6 до 45%. Исследования, посвященные особенностям течения сочетанных инфекций COVID-19 с ОРИ различной этиологии у детей, единичны, разнонаправленны и дискуссионны, что требует дальнейшего изучения данной проблемы.

The urgency of the problem of combined infection of COVID-19 with ARI of various etiologies is due to the high prevalence of respiratory infections during the epidemic of coronavirus infection. The prevalence of combined COVID-19 infections with ARI according to the literature varies from 0.6 to 45%. Studies devoted to the peculiarities of the course of combined COVID-19 infections with ARI of various etiologies in children are isolated, multidirectional and debatable, which requires further study of this problem.

COVID-19ОРИострые респираторные вирусные инфекции (ОРВИ)COVID-19ARIacute respiratory viral infections (ARVI)ReferencesВременные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 17 (14.12.2022).[Temporary methodological recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 17 (14.12.2022) (In Russ.)]Yakovlev A. S. еt al. SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children in Moscow in 2020. Int J Infect Dis. 2022 Mar; 116:331—338. doi: 10.1016/j.ijid.2021.12.358.Yakovlev A. S. еt al. SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses: SARS-CoV-2 infection in children in Moscow in 2020. Int J Infect Dis. 2022 Mar; 116:331—338. doi: 10.1016/j.ijid.2021.12.358.Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020 Sep-Oct; 41(5):102573. doi: 10.1016/j.amjoto.2020.102573.Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020 Sep-Oct; 41(5):102573. doi: 10.1016/j.amjoto.2020.102573.Беляков Н.А., и др. Пандемия COVID-19 и ее влияние на течение других инфекций на Северо-Западе России. ВИЧ-инфекция и иммуносупрессии. 2022; 14(1):7—24. https://doi.org/10.22328/2077-9828-2022-14-1-7-24[Belyakov N.A., et al. The COVID-19 pandemic and its effect on the course of other infections in the North-the West of Russia. HIV Infection and Immunosuppression. 2022; 14(1):7—24. (In Russ.)]Киселева И.В., и др. Особенности циркуляции респираторных вирусов в преди пандемические по гриппу и COVID-19 периоды. Инфекция и иммунитет. 2021; 11(6):1009—1019 doi: 10.15789/2220-7619-SFO-166[Kiseleva I.V., et al. Features of the circulation of respiratory viruses in preand pandemic influenza and COVID-19 periods. Infection and immunity. 2021; 11(6):1009—1019. (In Russ.)]Lansbury L, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; S0163— 4453(20)30323—6. doi:10.1016/j. jinf.2020.05.046Lansbury L, et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; S0163— 4453(20)30323—6. doi:10.1016/j. jinf.2020.05.046Guan Z, et al. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front Public Health. 2021 Dec10; 9:773130. doi:10.3389/fpubh.2021.773130.Guan Z, et al. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front Public Health. 2021 Dec10; 9:773130. doi:10.3389/fpubh.2021.773130.Swets MC, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022 Apr16; 399(10334):1463—1464. doi: 10.1016/S0140-6736(22)00383-X.Swets MC, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022 Apr16; 399(10334):1463—1464. doi: 10.1016/S0140-6736(22)00383-X.Wu HY, et al. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment. J Microbiol Immunol Infect. 2022 Dec; 55(6 Pt 1):985—992. doi: 10.1016/j.jmii.2022.09.006.Wu HY, et al. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment. J Microbiol Immunol Infect. 2022 Dec; 55(6 Pt 1):985—992. doi: 10.1016/j.jmii.2022.09.006.Rawson T.M., et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020; 71:2459—2468.Rawson T.M., et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020; 71:2459—2468.Baskaran V. , et al. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. J Med Microbiol. 2021 Apr; 70(4):001350. doi: 10.1099/jmm.0.001350Baskaran V. , et al. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. J Med Microbiol. 2021 Apr; 70(4):001350. doi: 10.1099/jmm.0.001350Harun Agca, et al. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. Journal of Infection and Public Health. 2021. 14:9:1186—1190. https://doi.org/10.1016/j.jiph.2021.08.004.Harun Agca, et al. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. Journal of Infection and Public Health. 2021. 14:9:1186—1190. https://doi.org/10.1016/j.jiph.2021.08.004.Hoque MN, et al. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microb Pathog. 2021 Jul; 156:104941. doi:10.1016/j.micpath.2021.104941.Hoque MN, et al. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis. Microb Pathog. 2021 Jul; 156:104941. doi:10.1016/j.micpath.2021.104941.Зверева Н.Н., и др. Случаи ко-инфекции COVID-19 и кори у детей. Эпидемиология и Вакцинопрофилактика. 2021; 20(6):81— 87. https://doi.org/10.31631/2073-3046-2021-20-6-81-87[Zvereva N.N., et al. A case of COVID-19 co-infection and measles in children. Epidemiology and Vaccination Prevention. 2021; 20(6):81—87. (In Russ.)]Сhih-Cheng Lai, et al. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?, Journal of Microbiology, Immunology and Infection. 2020; 53(4):505—512. https://doi.org/10.1016/j.jmii.2020.05.013.Сhih-Cheng Lai, et al. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?, Journal of Microbiology, Immunology and Infection. 2020; 53(4):505—512. https://doi.org/10.1016/j.jmii.2020.05.013.Pooneh Malekifar, et al. Viral Coinfection among COVID-19 Patient Groups: An Update Systematic Review and Meta-Analysis. BioMed Research International, 2021:10. https://doi.org/10.1155/2021/5313832Pooneh Malekifar, et al. Viral Coinfection among COVID-19 Patient Groups: An Update Systematic Review and Meta-Analysis. BioMed Research International, 2021:10. https://doi.org/10.1155/2021/5313832Leuzinger К. et al. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2020 Jul 29: jiaa464. doi: 10.1093/infdis/jiaa46418.Leuzinger К. et al. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2020 Jul 29: jiaa464. doi: 10.1093/infdis/jiaa46418.Munblit D., et al. Sechenov StopCOVID Research Team. Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clin Infect Dis. 2021 Jul 1; 73(1):1—11. doi: 10.1093/cid/ciaa1535.Munblit D., et al. Sechenov StopCOVID Research Team. Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clin Infect Dis. 2021 Jul 1; 73(1):1—11. doi: 10.1093/cid/ciaa1535.Порядок ведения детей с острыми респираторными инфекциями, в том числе COVID-19, находящихся на амбулаторном лечении в медицинских организациях государственной системы здравоохранения города Москвы, 2021 г.[The procedure for the management of children with acute respiratory infections, including COVID-19, who are on outpatient treatment in medical organizations of the state healthcare system of the city of Moscow, 2021. (In Russ.)]Hanada S., et al. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol. 2018 Nov 16; 9:2640. doi: 10.3389/fimmu.2018.02640.Hanada S., et al. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol. 2018 Nov 16; 9:2640. doi: 10.3389/fimmu.2018.02640.Зайцева С.В., и др. Микоплазменная инфекция у детей (обзор литературы). РМЖ. 2017; 5:327—334.[Zaitseva S.V., et al. Mycoplasma infection in children (literature review). RMJ. 2017; 5:327—334. (In Russ.)]Waites K.B., et al. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004. 17(4): 697—728.Waites K.B., et al. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004. 17(4): 697—728.Blasi F., et al. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med. 2005 Dec; 26(6):617—24. doi: 10.1055/s-2005-925525.Blasi F., et al. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med. 2005 Dec; 26(6):617—24. doi: 10.1055/s-2005-925525.Kleemola M., et al. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 1988; 157:230.Kleemola M., et al. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 1988; 157:230.Augenbraun M.H., et al. Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture. Am J Med. 1991; 91:437.Augenbraun M.H., et al. Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture. Am J Med. 1991; 91:437.Юлиш Е.И., и др. Респираторная инфекция, вызванная Chlamydophila pneumonia, у детей. Подходы к диагностике и лечению. Здоровье ребенка. 2013; 8(51):127—131.[Yulish E.I., et al. Respiratory infection caused by Chlamydophila pneumoniae in children. Approaches to diagnosis and treatment. Zdorov'ye Rebenka. 2013; 8(51):127—131. (In Russ.)]Wu Q, et al. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics. 2020 Jul;146(1):e20200961. doi: 10.1542/peds.2020-0961Wu Q, et al. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics. 2020 Jul;146(1):e20200961. doi: 10.1542/peds.2020-0961Oliva, A., et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020; 48:871—877. https://doi.org/10.1007/s15010-020-01483-8Oliva, A., et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020; 48:871—877. https://doi.org/10.1007/s15010-020-01483-8Gayam V, et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and mycoplasma pneumoniae in the USA. J Med Virol. 2020. https://doi.org/10.1002/jmv.26026.Gayam V, et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and mycoplasma pneumoniae in the USA. J Med Virol. 2020. https://doi.org/10.1002/jmv.26026.De Francesco M.A., et al. Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J. Infect, 2021; 82:e4—e7.De Francesco M.A., et al. Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J. Infect, 2021; 82:e4—e7.Richardson S., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323:2052—9. https://doi.org/10.1001/jama.2020.6775Richardson S., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323:2052—9. https://doi.org/10.1001/jama.2020.6775Mirzaei R., et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020 Oct; 72(10):2097—2111. doi: 10.1002/iub.2356.Mirzaei R., et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020 Oct; 72(10):2097—2111. doi: 10.1002/iub.2356.Amin D., et al. Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients. J Med Virol, 2021; 93:1180—1183.Amin D., et al. Association of mortality and recent Mycoplasma pneumoniae infection in COVID-19 patients. J Med Virol, 2021; 93:1180—1183.Gayam V., et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J Med Virol, 2020; 92:2181—2187.Gayam V., et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J Med Virol, 2020; 92:2181—2187.Hoang A., et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020 Jun 26; 24:100433. doi: 10.1016/j.eclinm.2020.100433.Hoang A., et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020 Jun 26; 24:100433. doi: 10.1016/j.eclinm.2020.100433.Zhang J-J, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. https://doi.org/10.1111/all.14238Zhang J-J, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. https://doi.org/10.1111/all.14238Chaudhry R., et al. Atypical bacterial co-infections among patients with COVID-19: A study from India. J Med Virol. 2021; 94:303—309. https://doi.org/10.1002/jmv.27324Chaudhry R., et al. Atypical bacterial co-infections among patients with COVID-19: A study from India. J Med Virol. 2021; 94:303—309. https://doi.org/10.1002/jmv.27324Kuitunen, I. Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Findings in Children During COVID-19 Pandemic in Finland. SN Compr. Clin. Med. 2022; 4(154). https://doi.org/10.1007/s42399-022-01251-9Kuitunen, I. Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Findings in Children During COVID-19 Pandemic in Finland. SN Compr. Clin. Med. 2022; 4(154). https://doi.org/10.1007/s42399-022-01251-9Plebani A., et al. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children. Clin Immunol. 2020 Dec; 221:108613. doi: 10.1016/j.clim.2020.108613.Plebani A., et al. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children. Clin Immunol. 2020 Dec; 221:108613. doi: 10.1016/j.clim.2020.108613.Ogunbayo AE, et al. Pathogen Profile of Children Hospitalised with Severe Acute Respiratory Infections during COVID-19 Pandemic in the Free State Province, South Africa. Int J Environ Res Public Health. 2022 Aug 21; 19(16):10418. doi: 10.3390/ijerph191610418.Ogunbayo AE, et al. Pathogen Profile of Children Hospitalised with Severe Acute Respiratory Infections during COVID-19 Pandemic in the Free State Province, South Africa. Int J Environ Res Public Health. 2022 Aug 21; 19(16):10418. doi: 10.3390/ijerph191610418.Liu, P. et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol. J. 2021; 18(159).Liu, P. et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol. J. 2021; 18(159).Tempia, S., et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Eurosurveillance. 2021; 26:2001600.Tempia, S., et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Eurosurveillance. 2021; 26:2001600.Han H., et al. Prevalence of Non-SARS-CoV-2 Respiratory Pathogens and Co-Infection with SARS-CoV-2 in the Early Stage of COVID-19 Epidemic. Pathogens. 2022 Nov 4; 11(11):1292. doi: 10.3390/pathogens11111292.Han H., et al. Prevalence of Non-SARS-CoV-2 Respiratory Pathogens and Co-Infection with SARS-CoV-2 in the Early Stage of COVID-19 Epidemic. Pathogens. 2022 Nov 4; 11(11):1292. doi: 10.3390/pathogens11111292.Li Y., et al. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children: A retrospective study. Medicine. 2021; 100:e24315.Li Y., et al. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children: A retrospective study. Medicine. 2021; 100:e24315.Li B., et al. Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis. Front. Pediatr. 2020; 8:591132.Li B., et al. Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis. Front. Pediatr. 2020; 8:591132.Chan K.-S., et al. Collateral benefits on other respiratory infections during fighting COVID-19. Med. Clínica (Engl. Ed.) 2020; 155:249—253.Chan K.-S., et al. Collateral benefits on other respiratory infections during fighting COVID-19. Med. Clínica (Engl. Ed.) 2020; 155:249—253.Adams K., et al. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021—22 Influenza Season. MMWR Morb Mortal Wkly Rep. 2022 Dec 16; 71(50):1589—1596. doi: 10.15585/mmwr.mm7150a4.Adams K., et al. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021—22 Influenza Season. MMWR Morb Mortal Wkly Rep. 2022 Dec 16; 71(50):1589—1596. doi: 10.15585/mmwr.mm7150a4.How To Cite: Mardani M, Nasiri M J. Influenza and COVID-19 Co-infection. Arch Clin Infect Dis.17(3):e131750. doi: 10.5812/archcid-131750.How To Cite: Mardani M, Nasiri M J. Influenza and COVID-19 Co-infection. Arch Clin Infect Dis.17(3):e131750. doi: 10.5812/archcid-131750.Pata D., et al. Comparison of the Clinical and Laboratory Features of COVID and Influenza in Children. Mediterr JHematol Infect Dis. 2022 Sep 1;14(1):e2022065. doi: 10.4084/MJHID.2022.065.Pata D., et al. Comparison of the Clinical and Laboratory Features of COVID and Influenza in Children. Mediterr JHematol Infect Dis. 2022 Sep 1;14(1):e2022065. doi: 10.4084/MJHID.2022.065.Vink Е., et al. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study. Open Forum Infectious Diseases, 2022; 9(11): ofac531 https://doi.org/10.1093/ofid/ofac531Vink Е., et al. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study. Open Forum Infectious Diseases, 2022; 9(11): ofac531 https://doi.org/10.1093/ofid/ofac531Jiang S, Liu P, Xiong G, Yang Z, Wang M, Li Y, Yu XJ. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children. Clin Chem Lab Med. 2020 Jun 25; 58(7):1160—1161. doi: 10.1515/cclm-2020-0434. PMID: 32301747.Jiang S, Liu P, Xiong G, Yang Z, Wang M, Li Y, Yu XJ. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children. Clin Chem Lab Med. 2020 Jun 25; 58(7):1160—1161. doi: 10.1515/cclm-2020-0434. PMID: 32301747.Alhumaid S., et al. Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2022 Nov 15; 7(11):380. doi: 10.3390/tropicalmed7110380.Alhumaid S., et al. Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2022 Nov 15; 7(11):380. doi: 10.3390/tropicalmed7110380.Zimmermann P., Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. The Pediatric infectious disease journal. 2020; 39(5):355. doi: 10.1097/INF.0000000000002660Zimmermann P., Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. The Pediatric infectious disease journal. 2020; 39(5):355. doi: 10.1097/INF.0000000000002660

The authors declare that there are no conflicts of interest present.